HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Norihiro Aibe Selected Research

AK 2123

4/2013Intensity-modulated radiation therapy with hypoxic sensitizer AK-2123 (sanazole) for glioblastoma multiforme using simultaneous integrated boost technique.
4/2013Hypofractionated stereotactic radiotherapy with the hypoxic sensitizer AK-2123 (sanazole) for reirradiation of brain metastases: a preliminary feasibility report.
2/2013Feasibility trial for daily oral administration of the hypoxic sensitizer AK-2123 (Sanazole) in radiotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Norihiro Aibe Research Topics

Disease

16Prostatic Neoplasms (Prostate Cancer)
06/2022 - 12/2013
12Neoplasms (Cancer)
05/2022 - 01/2011
5Neoplasm Metastasis (Metastasis)
03/2021 - 06/2017
5Esophageal Neoplasms (Esophageal Cancer)
05/2019 - 01/2017
4Breast Neoplasms (Breast Cancer)
01/2019 - 01/2011
4Dermatitis
11/2018 - 01/2011
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2021 - 01/2017
2Radiation Pneumonitis
10/2017 - 05/2014
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2022
1Head and Neck Neoplasms (Head and Neck Cancer)
02/2022
1Second Primary Neoplasms (Neoplasms, Second)
07/2021
1Wilms Tumor (Wilm's Tumor)
09/2019
1Pain (Aches)
02/2018
1Bone Diseases (Bone Disease)
02/2018
1Chordoma
01/2018
1Pneumonia (Pneumonitis)
10/2017
1Papillary Carcinoma
09/2017
1Thyroid Neoplasms (Thyroid Cancer)
09/2017
1Deglutition Disorders (Dysphagia)
01/2017
1Hemangiosarcoma (Angiosarcoma)
11/2016
1Hepatocellular Carcinoma (Hepatoma)
02/2016
1Lung Neoplasms (Lung Cancer)
12/2014
1Diabetes Mellitus
05/2014
1Nausea
04/2013
1Glioblastoma (Glioblastoma Multiforme)
04/2013
1Brain Neoplasms (Brain Tumor)
04/2013
1Paresthesia (Dysesthesia)
02/2013
1Body Weight (Weight, Body)
07/2012
1Pituitary Neoplasms (Pituitary Adenoma)
01/2011
1Meningioma (Meningiomas)
01/2011
1Necrosis
01/2011
1Hemorrhage
01/2011

Drug/Important Bio-Agent (IBA)

3AK 2123IBA
04/2013 - 02/2013
2AndrogensIBA
07/2020 - 03/2019
2Radiation-Sensitizing AgentsIBA
04/2013 - 02/2013
1Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
10/2017
1Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2017
1Glycoside Hydrolase InhibitorsIBA
05/2014
1Pharmaceutical PreparationsIBA
04/2013
1Temozolomide (Temodar)FDA LinkGeneric
04/2013

Therapy/Procedure

34Radiotherapy
06/2022 - 01/2011
9Brachytherapy
06/2022 - 11/2018
9Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
04/2021 - 12/2013
7Therapeutics
07/2020 - 01/2011
6Re-Irradiation
02/2022 - 01/2011
3Proton Therapy
07/2021 - 01/2018
2Segmental Mastectomy (Lumpectomy)
01/2018 - 07/2012
2Oral Administration
04/2013 - 02/2013
1Chemoradiotherapy
12/2018
1Esophagectomy
12/2018
1Thyroidectomy
09/2017
1Conformal Radiotherapy
06/2017
1Aftercare (After-Treatment)
01/2017
1Image-Guided Radiotherapy
05/2014
1Adjuvant Radiotherapy
02/2013
1Intravenous Administration
02/2013